SEC Form 4 · accession 0001038133-16-000326
HESKA CORP · HSKA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael J McGinley
Officer — Pres., Biologic. & Pharm.
Period of report
Nov 15, 2016
Accepted (ET)
Nov 16, 2016 · 12:25 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001038133
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 15, 2016 | M | 1 | $17.17 | A | 116,237 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F1 | $17.17 | Nov 15, 2016 | M | 1 | D | Nov 17, 2006 | Nov 17, 2006 | Common Stock | 1 | 0 | D |
Explanation of responses
- F1Represents a combination of stock option exercises involving fractional shares: 0.6 shares at a price of $17.17 per share from a stock option granted on 11/17/06 exercisable on 11/17/2010 with an expiration date of 11/17/2016 and 0.4 shares at a price of $17.17 per share from a stock option granted on 11/17/06 exercisable on 11/17/2010 with an expiration date of 11/17/2016.